Ophthalmology Times Europe October 2023

No two corneal ulcers are alike, but if they are large and centrally located, the common denominator is that time is of the essence

For clinicians, the evolution of treatment is as much a responsibility as an opportunity

The price tag of publishing presents a tricky research barrier

With investigations into CVI in the early phases, collaboration across the Atlantic is crucial

An inflammation-based view of both ophthalmic and neurologic health

Investigators emphasised a significant unmet need for home-based monitoring of visual function with patient-centric technologies

For retinal specialists grappling with diseases once thought “untreatable,” gene therapies present a wide range of viable options

Laser scleral microporation rejuvenates dynamic range of focus by increasing scleral pliability, allowing underlying structures to move more freely

Results showed that the PAUL Glaucoma Implant is an effective glaucoma drainage device that provides effective IOP lowering, similar to that achieved with the Baerveldt Glaucoma Implant, but with lower rates of complications